Among patients with COVID-19, evidence exists of high levels of proinflammatory cytokines and chemokines leading to an increase in the severity of COVID-19 infections, higher consumption of CD4+ and CD8+ T-cells, decrease in regulatory T-cells, and a altered innate immune environment leading to a cytokine storm and worsen damaged tissue40,41. This evidence concerns the gene CD4 and COVID-19.